Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: Results from the DIMCA programme

European Journal of General Practice

Volumn 13, Issue 2, 2007, Pages 89-91

  den Otter, Joost J ^a   van Schayck, Constant P ^a   Folgering, Hans T M ^a   van den Boom, Guido ^a   Akkermans, Reinier P M ^a   van Weel, Chris ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; COPD; Early intervention; General practice

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; PLACEBO;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EARLY INTERVENTION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANDROSTADIENES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; DOUBLE-BLIND METHOD; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; NETHERLANDS; PLACEBOS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 34249907528     PISSN: 13814788     EISSN: None     Source Type: Journal    
DOI: 10.1080/13814780701377455     Document Type: Article

References (6)

1. Laitinen, LA, Laitinen, A. and Haahtela, T. (1993) Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis, 139, pp. 806-817.
2. Dompeling, E., van Schayck, CP, van Grunsven, PM, van Herwaarden, CLA, Akkermans, RPM and Molema, J. (1993) Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med, 118, pp. 770-778.
3. Boom, G van den, Molken, MPM Rutten-van, Tirimanna, PRS, van Schayck, CP, Folgering, HTM and van Weel, C. (1998) Association between health-related quality of life and consultation for respiratory symptoms: Results from the DIMCA programme. Eur Respir J, 11, pp. 67-72.
4. Siafakas, NM, Vermeire, P., Pride, NB, Paoletti, P., Gibson, J. and Howard, P. (1995) Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J, 8, pp. 1398-1420.
5. Haahtela, T., Jarvinen, M., Kava, T., Kiviranta, K., Koskinen, S. and Lehtonen, K. (1994) Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med, 331, pp. 700-705.
6. O'Byrne, PM, Cuddy, L., Taylor, DW, Birch, S., Morris, J. and Syrotuik, J. (1996) Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care. Can Respir J, 3, pp. 169-175.